COVID-19 Inflammatory Diversity: Could MSC-derived Exosomes Solve This Mystery?
The coronavirus disease-19 (COVID-19) pandemic has caused the world unspeakable harm. Given how quickly the pandemic has spread, it is crucial to think of a variety of treatment alternatives in order to successfully treat people worldwide. Since the immune system is the focal point of the infection, it is crucial to control the dynamic equilibrium in order to avoid exaggerated immunological responses that ultimately cause harm to several organs. In the last ten years, there has been a significant increase in the use of stem cells for medical purposes. Mesenchymal stem cells (MSCs) and exosomes isolated from MSCs (MSC-Exo) have been made available to the world as potential therapeutics for a wide range of ailments as a result of scientifically ground-breaking methods. Patients with COVID-19 may benefit from using MSCs and MSC-Exos as a therapy to regulate their immune systems because they have immunomodulatory properties. MSC-Exosomes and Immunomodulation It is now recognised that